Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis. - Wikidata - awgldk - TriplyDB

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.

http://www.wikidata.org/entity/Q42563536

about

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.High resolution melting analysis: a rapid and accurate method to detect CALR mutations.Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells Screening PCR Versus Sanger Sequencing: Detection of CALR Mutations in Patients With Thrombocytosis Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia Clinical Manifestation of Calreticulin Gene Mutations in Essential Thrombocythemia without Janus Kinase 2 and MPL Mutations: A Chinese Cohort Clinical Study.Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.Calreticulin gene mutations in myeloproliferative neoplasms without Janus kinase 2 mutations.Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring.Calreticulin mutations in myeloproliferative neoplasms.Clinical validation of a multipurpose assay for detection and genotyping of CALR mutations in myeloproliferative neoplasms.Clinical relevance between CALR mutation and myeloproliferative neoplasms.JAK2, MPL, and CALR mutations in Chinese Han patients with essential thrombocythemia.Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysis.Somatic mutations of calreticulin in a Brazilian cohort of patients with myeloproliferative neoplasms.Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis.JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms.CALR mutations in myeloproliferative neoplasms: hidden behind the reticulum.A rapid, highly accurate method for quantifying CALR mutant allele burden in persons with myeloproliferative neoplasms.Validation of a molecular diagnostic assay for CALR exon 9 indels in myeloproliferative neoplasms: identification of coexisting JAK2 and CALR mutations and a novel 9 bp deletion in CALR.EAGLE: Explicit Alternative Genome Likelihood Evaluator.Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution

P2860

Q33828563-0B1D9E34-1915-4894-BAA7-B91125A16290 Q35214151-C664CB28-0F5F-4D4B-A25F-A0A0F456AD77 Q36557368-8616DE48-96EC-45B1-B4C1-3524B9E1DA6D Q36864296-69F5CC97-B021-48E7-AA66-25AA30F2F992 Q37048522-B41B59D6-A770-4F83-8AEB-04B25EDD7EFA Q37157892-EE57B8A9-9CE5-4A96-9AD0-2A67B3FF9A61 Q37636747-75218116-B8A0-4BC1-9D8E-21B7C454A3FF Q38239217-6EF528CE-7FF5-407F-9796-9957CA94469F Q38263140-A2C6948A-7972-4248-9FA7-D47E798590A6 Q38266905-61C4AF38-DE4D-404C-B387-7AABA7121645 Q38826302-990BAB58-39AD-4F4D-B5A7-B78DCBED444E Q38881482-66773005-D99F-4228-A5A2-DD6CC9DED5CA Q39162818-10B7D7BB-3F60-4BFD-89EC-92BA7AB69239 Q41519713-92BAC3BE-AF49-4998-9E4F-1DD6A5E5B42E Q42585822-398C7346-E0EC-4E76-9B08-2800BCAC0DDB Q42919390-BFDEF26E-E90D-49E7-8D6E-5475ADBAEB34 Q42940564-10510F81-AE07-4D6F-8B5A-1CBC0C7B9E82 Q45961187-593BC543-D15C-4E6A-80CF-E6F459A86B84 Q53550692-CF0CFCAC-7F53-476B-9F6D-183033264515 Q55026206-088D667C-418C-45C2-A1EF-E0922C012779 Q55395587-6555B348-3996-49A5-A49F-3AF8FC08FDB9 Q57219501-34CEE103-E5B5-4CBE-BB4F-8BE9E0355498

P2860

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.

http://www.wikidata.org/entity/Q42563536

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.

@en

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.

@nl

type

label

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.

@en

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.

@nl

prefLabel

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.

@en

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.

@nl

P1433

Q42563536-06650766-D309-43D3-8215-67699A9B56A5

P1476

Q42563536-7F16D95D-BA52-4E47-B4F8-9745BAD473E5

P2093

Q42563536-00A08AEF-D4E2-46BA-8A17-4DED1148D974

Q42563536-2A1A6D3E-D80C-461B-BB6B-B1D5B5F424BD

Q42563536-37C51E3B-3A8A-403B-B4E9-486B8932BA2F

Q42563536-423FCF38-6D61-4D3F-8693-E8D43EFC98D9

Q42563536-59D2436F-06C9-4DFB-94AC-5066E9A105FB

Q42563536-5CC5392D-8DF8-44F0-8362-EC23E9F88709

Q42563536-8E254036-2155-4EE1-B97B-8E39333434F0

Q42563536-955A283D-8DB2-4247-9A03-EDBD024AB564

Q42563536-EE618884-4B4C-4BE0-8B7E-53B7678E73D6

Q42563536-EE998399-8B50-427F-85A5-128C0B0BF4D5

P2860

Q42563536-02EE21AE-0D93-4319-8043-DEAFC22C335B

Q42563536-064EBBD4-8509-47F9-851F-7FA5F5B5220C

Q42563536-12D82CEC-815F-4AF3-B4FB-D1F9E557A6C9

Q42563536-1CB91605-FE71-4963-A2EE-3EEB5C3F5CD9

Q42563536-31468411-A64F-477E-B3D7-531332ADB0C8

Q42563536-75F0A4A4-7545-4923-A0F9-E8A33D4C6E1E

Q42563536-77943D69-639E-4877-9C7D-D606A0F8D95F

Q42563536-7DB56573-3FD1-4A1A-A65E-B1A91124DFC4

Q42563536-8D8BF749-33A6-4429-A828-E2EC134A64D7

Q42563536-A2A4D8F0-4C31-4D0F-B849-B90482F1CB4C

P2888

Q42563536-0AA416DC-60C3-45C7-B157-654F7E9BDE15

P304

Q42563536-2A699D52-760F-4080-B943-9A7093E46B1D

P31

Q42563536-9F6ECFA2-70FB-4E06-B112-FF85ABC69617

P356

Q42563536-7F0D4FA8-2167-4304-B2D8-6DA26E892F3D

P433

Q42563536-7398496E-E615-44C8-9000-8846330EC037

P478

Q42563536-FC1332A5-0542-4131-B9F4-7E6763F8B635

P50

Q42563536-4D620DDF-042F-47B5-B97F-CCBC3379161D

Q42563536-60803468-0777-437D-BC90-189524AA254A

Q42563536-FCD7F693-0964-4A3F-AB36-B98A402542CA

P577

Q42563536-BC7CDB4F-A492-416F-8670-AA19B95EC855

P5875

Q42563536-6BB755AE-F01F-45FE-B491-8B01EA69A71E

P6179

Q42563536-98675E0E-27BF-4D9C-A636-A88CBC3F3319

P698

Q42563536-9D77CCD4-9E96-4341-9340-959E868204F3

P932

Q42563536-A00BEF26-BBEA-4326-96DC-1C1B536EE3E1

P356

P1433

P1476

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis

@en

P2093

A Mitsidou

http://www.w3.org/2001/XMLSchema#string

C Pierides

http://www.w3.org/2001/XMLSchema#string

C Prokopiou

http://www.w3.org/2001/XMLSchema#string

F Melanthiou

http://www.w3.org/2001/XMLSchema#string

J Chi

http://www.w3.org/2001/XMLSchema#string

K A Nicolaou

http://www.w3.org/2001/XMLSchema#string

K Barbouti

http://www.w3.org/2001/XMLSchema#string

L Koumas

http://www.w3.org/2001/XMLSchema#string

M Manoloukos

http://www.w3.org/2001/XMLSchema#string

P Costeas

http://www.w3.org/2001/XMLSchema#string

P2860

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

Guideline for investigation and management of adults and children presenting with a thrombocytosis

Calreticulin: non-endoplasmic reticulum functions in physiology and disease.

Calreticulin: one protein, one gene, many functions.

Somatic mutations of calreticulin in myeloproliferative neoplasms.

Calreticulin enhances porcine wound repair by diverse biological effects.

Expression of calreticulin in Escherichia coli and identification of its Ca2+ binding domains.

The anti-adhesive activity of thrombospondin is mediated by the N-terminal domain of cell surface calreticulin.

Crucial role for endoplasmic reticulum stress during megakaryocyte maturation.

ERp57 modulates STAT3 signaling from the lumen of the endoplasmic reticulum

P2888

P304

1152-1154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2013.382

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

George S Vassiliou

Vicky Nicolaidou

P577

2013-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259455287

http://www.w3.org/2001/XMLSchema#string

P6179

1023157935

http://www.w3.org/2001/XMLSchema#string

P698

24365789

http://www.w3.org/2001/XMLSchema#string

P932

4017256

http://www.w3.org/2001/XMLSchema#string